Dow Down1.29% Nasdaq Down3.25%

Valeant Pharmaceuticals International, Inc. (VRX)

96.59 Down 0.35(0.36%) Feb 5, 4:01PM EST
|After Hours : 96.25 Down 0.34 (0.35%) Feb 5, 7:59PM EST
ProfileGet Profile for:
Valeant Pharmaceuticals International, Inc.
2150 St. Elzéar boulevard West
Laval, QC H7L 4A8
Canada - Map
Phone: 514-744-6792
Fax: 514-744-6272

Index Membership:N/A
Industry:Drug Delivery
Full Time Employees:16,800

Business Summary 

Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Wellbutrin XL for major depressive disorder in adults; Jublia for onychomycosis of the toenails; Xenazine for chorea; Targretin for Cutaneous T-Cell Lymphoma; Arestin, a subgingival sustained-release antibiotic; and PROVENGE for the treatment of prostate cancer. It also provides Zovirax, an antiviral for recurrent herpes labialis and initial genital herpes; Syprine to treat patients with Wilson's disease; Elidel to treat atopic dermatitis; Prolensa for inflammation and pain following cataract surgery; Duromine, a weight loss drug; and Lotemax gel for post-operative inflammation and pain. In addition, the company offers PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; ReNu Multiplus to lubricate and rewet soft contact lenses; Biotrue for healthy contact lens wear; Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; AntiGrippin for acute respiratory and respiratory viral diseases, and influenza; and Bedoyecta, a vitamin B complex product. Further, it provides SofLens daily disposable contact lenses; PureVision, a contact lens; various ophthalmic surgical products; Biotrue ONEday lens; medical device systems for aesthetic applications; and Bausch + Lomb Ultra, a contact lens. Additionally, the company offers Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Cardizem CD to treat hypertension and angina; and Latanoprost for the treatment of glaucoma. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Valeant Pharmaceuticals International, Inc.

Corporate Governance 
Valeant Pharmaceuticals International, Inc.’s ISS Governance QuickScore as of Feb 1, 2016 is 1. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 2; Compensation: 1.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Howard Bradley Schiller , 54
Interim Chief Exec. Officer and Director
Mr. J. Michael Pearson , 57
Chairman, Chief Exec. Officer and Director(Leave of absence)
Mr. Robert Roswell Chai-Onn , 46
Chief Legal Officer, Exec. VP, Head of Corp. & Bus. Devel. and Gen. Counsel
Mr. Pavel Mirovsky , 65
Pres of Valeant Europe and Gen. Mang. of Valeant Europe
Dr. Ari S. Kellen , 53
Exec. VP and Company Group Chairman
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders